Tempest Therapeutics (3OS0.F) Q1 2025 Earnings

27MarConfirmed
Q1 2025
-3.73
-3.5
-3.26
-3.03

Details

Expected EPS
-3.0313668112
Actual EPS
-3.7311352
Surprise EPS
-0.7
Surprise Percent
+23.08%

Description

Tempest Therapeutics (3OS0.F) has reported earnings of -3.7311352 per share for Q1 2025.

0 Comments

Share your thoughts